Branch segment occlusion with acute myocardial infarction is a risk for left ventricular free wall rupture

Circulation Journal

Volumn 73, Issue 8, 2009, Pages 1473-1478

  Ino, Yasushi ^a   Kubo, Takashi ^a   Tomobuchi, Yoshiaki ^a   Oshika, Hiroyuki ^a   Kitabata, Hironori ^a   Obana, Masahiro ^a   Tanimoto, Takashi ^a   Takarada, Shigeho ^a   Tanaka, Atsushi ^a   Imanishi, Toshio ^a   Okamura, Yoshitaka ^a   Akasaka, Takashi ^a  

^a WAKAYAMA MEDICAL UNIVERSITY   (Japan)

Author keywords

Acute myocardial infarction; Branch segment occlusion; Left ventricular free wall rupture; Primary PCI

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CREATINE KINASE; CREATINE KINASE MB; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HEART ENZYME; TISSUE PLASMINOGEN ACTIVATOR;

ACUTE HEART INFARCTION; ADULT; AGED; ANGIOCARDIOGRAPHY; AORTA BALLOON; ARTICLE; CORONARY ARTERY; CREATINE KINASE BLOOD LEVEL; DISEASE SEVERITY; DOPPLER ECHOCARDIOGRAPHY; FEMALE; HEART ATRIOVENTRICULAR NODE; HEART FUNCTION; HEART INFARCTION SIZE; HEART LEFT VENTRICLE WALL; HEART RUPTURE; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; PERCUTANEOUS CORONARY INTERVENTION; PREDICTION; RETROSPECTIVE STUDY; RISK FACTOR;

AGED; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; ARTERIAL OCCLUSIVE DISEASES; CORONARY ARTERY DISEASE; HEART RUPTURE; HOSPITAL MORTALITY; HUMANS; INCIDENCE; MIDDLE AGED; MYOCARDIAL INFARCTION; PREDICTIVE VALUE OF TESTS; RETROSPECTIVE STUDIES; RISK;

EID: 69049094117     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.CJ-08-1112     Document Type: Article

References (37)

1. Killip T, Kimball J. Treatment of myocardial infarction in a coronary care unit: A two year experience with 250 patients. Am J Cardiol 1967; 20: 457-464.
2. Tofler GH, Muller JE, Stone PH. Factors leading to shorter survival after acute myocardial infarction in patients aging 65 to 75 years compared with younger patients. Am J Cardiol 1988; 62: 860-867.
3. Risk stratification and survival after myocardial infarction. N Engl J Med 1983; 309: 331-336.
4. Stevenson R, Ranjadayalan K, Wilkinson P, Roberts R, Timmis AD. Short and long term prognosis of acute myocardial infarction since introduction of thrombolysis. BMJ 1993; 307: 349-353.
5. Keeley EC, Boura JA, Grines CL. Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: A quantitative review of 23 randomised trials. Lancet 2003; 361: 13-20.
6. Hands ME, Lloyd BL, Robinson JS, De Klerk N, Thompson PL. Prognostic significance of electrocardiographic site of infarction after correction for enzymatic size of infarction. Circulation 1986; 73: 885-891.
7. Zijlstra F, Hoorntje JC, de Boer MJ, Reiffers S, Miedema K, Ottervanger JP, et al. Long-term benefit of primary angioplasty as compared with thrombolytic therapy for acute myocardial infarction. N Engl J Med 1999; 341: 1413-1419.
8. Kaneko H, Yaoita H, Iwai-Takano M, Watanabe N, Sakamoto K, Seino Y, et al. Prediction of remote left ventricular volumes and functions after acute myocardial infarction with successful coronary intervention. Circ J 2008; 72: 226-231.
9. Tani S, Nagao K, Watanabe I, Kikushima K, Watanabe K, Anazawa T, et al. Increasingly well-preserved left ventricular function in hospital survivors with acute myocardial infarction. Circ J 2007; 71: 180-185.
10. Herlitz J, Samuelsson SO, Richter A, Hjalmarson A. Prediction of rupture in acute myocardial infarction. Clin Cardiol 1988; 11: 63-69.
11. Solberg S, Nordrum I, Fausa D, Jørgensen L. Cardiac ruptures in northern Norway: A retrospective study of 104 cases. Acta Med Scand 1988; 224: 303-310.
12. Yamaguchi J, Kawaguchi M, Kawana M, Asano R, Sumiyoshi T, Kasanuki H. Risk factors and effect of reperfusion therapy on left ventricular free wall rupture following acute myocardial infarction. J Cardiol 2000; 35: 257-265.
13. Austen WG, Edwards JE, Frye RL, Gensini GG, Gott VL, Griffith LS, et al. A reporting system on patients evaluated for coronary artery disease: Report of the Ad Hoc Committee for Grading of Coronary Artery Disease, Council on Cardiovascular Surgery, American Heart Association. Circulation 1975; 51(Suppl): 5-40.
14. Becker RC, Hochman JS, Cannon CP, Spencer FA, Ball SP, Rizzo MJ, et al. Fatal cardiac rupture among patients treated with thrombolytic agents and thrombin antagonists. J Am Coll Cardiol 1999; 33: 479-487.
15. Moreno R, López SJ, García E, Pérez IL, López SE, Ortega A, et al. Primary angioplasty reduces the risk of left ventricular free wall rupture compared with thrombolysis in patients with acute myocardial infarction. J Am Coll Cardiol 2002; 39: 598-603.
16. Ikeda N, Yasu T, Kubo N, Hirahara T, Sugawara Y, Kobayashi N, et al. Effect of reperfusion therapy on cardiac rupture after myocardial infarction in Japanese. Circ J 2004; 68: 422-426.
17. Yip HK, Wu CJ, Chang HW, Wang CP, Cheng CI, Chua S, et al. Cardiac rupture complicating acute myocardial infarction in the direct percutaneous coronary intervention reperfusion era. Chest 2003; 124: 565-571.
18. Moreno R, López SE, López SJ, García E, Soriano J, Abeytua M, et al. Free wall rupture in patients with acute myocardial infarction treated with primary angioplasty: Incidence and related factors. Am J Cardiol 2000; 85: 757-760.
19. Ohishi F, Hayasaki K, Honda T. Effect of thrombolysis on rupture of the left ventricular free wall following acute myocardial infarction. J Cardiol 1996; 28: 27-32.
20. Katayama T, Nakashima H, Takagi C, Honda Y, Suzuki S, Iwasaki Y, et al. Serum amyloid A protein as a predictor of cardiac rupture in acute myocardial infarction patients following primary coronary angioplasty. Circ J 2006; 70: 530-535.
21. Shiraishi J, Kohno Y, Sawada T, Takeda M, Arihara M, Hyogo M, et al. Predictors of in-hospital outcome after primary percutaneous coronary intervention for recurrent myocardial infarction. Circ J 2008; 72: 1225-1229.
22. Becker RC, Gore JM, Lambrew C, Weaver WD, Rubison RM, French WJ, et al. A composite view of cardiac rupture in the United States national registry of myocardial infarction. J Am Coll Cardiol 1996; 27: 1321-1326.
23. Figueras J, Cortadellas J, Calvo F, Soler-Soler J. Relevance of delayed hospital admission on development of cardiac rupture during acute myocardial infarction: Study in 225 patients with free wall, septal or papillary muscle rupture. J Am Coll Cardiol 1998; 32: 135-139.
24. Figueras J, Alcalde O, Barrabes JA, Serra V, Alguersuari J, Cortadellas J, et al. Changes in hospital mortality rates in 425 patients with acute ST-elevation myocardial infarction and cardiac rupture over a 30-year period. Circulation 2008; 118: 2783-2789.
25. Becker AE, van Mantgem JP. Cardiac tamponade: A study of 50 hearts. Eur J Cardiol 1975; 3: 349-358.
26. Nakamura F, Minamino T, Higashino Y, Ito H, Fujii K, Fujita T, et al. Cardiac free wall rupture in acute myocardial infarction: Ameliorative effect of coronary reperfusion. Clin Cardiol 1992; 15: 244-250.
27. Nakatsuchi Y, Minamino T, Fujii K, Negoro S. Clinicopathological characterization of cardiac free wall rupture in patients with acute myocardial infarction: Difference between early and late phase rupture. Int J Cardiol 1994; 47: S33-S38.
28. Lautsch E, Lanks KW. Pathogenesis of cardiac rupture. Arch Pathol 1976; 84: 264-271.
29. Batts KP, Ackermann DM, Edwards WD. Post-infarction rupture of the left ventricular free wall: Clinicopathologic correlates in 100 consecutive autopsy cases. Hum Pathol 1990; 21: 530-535.
30. Becker RC, Charlesworth A, Wilcox RG, Hampton J, Skene A, Gore JM, et al, for the Late Assessment of Thrombolytic Efficacy Investigators. Cardiac rupture associated with thrombolytic therapy: Impact of time to treatment in the Late Assessment of Thrombolytic Efficacy (LATE) study. J Am Coll Cardiol 1995; 25: 1063-1068.
31. Radford MJ, Johnson RA, Daggett WM, Fallon JT, Buckley MJ, Gold HK, et al. Ventricular septal rupture: A review of clinical and physiologic features and an analysis of survival. Circulation 1981; 64: 545-553.
32. Held AC, Cole PL, Lipton B, Gore JM, Antman EM, Hockman JS, et al. Rupture of the interventricular septum complicating acute myocardial infarction: A multicenter analysis of clinical findings and outcome. Am Heart J 1988; 116: 1330-1336.
33. Bolooki H. Surgical treatment of complication of acute myocardial infarction. JAMA 1990; 263: 1237-1240.
34. Grines CL, Cox DA, Stone GW, Garcia E, Mattos LA, Giambartolomei A, et al. Coronary angioplasty withi or without stent implantation for acute myocardial infarction: Stent Primary Angioplasty in Myocardial Infarction Study Group. N Engl J Med 1999; 341: 1949-1956.
35. Suryapranata H, van't Hof AW, Hoorntje JC, de Boer MJ, Zijlstra F. Randomized comparison of coronary stenting with balloon angioplasty in selected patients with acute myocardial infarction. Circulation 1998; 97: 2502-2505.
36. Kruk M, Przyluski J, Kalinczuk L, Pregowski J, Kadziela J, Kaczmarska E, et al. Hemoglobin, leukocytosis and clinical outcomes of ST-elevation myocardial infarction treated with primary angioplasty: Anin Myocardial Infarction Registry. Circ J 2009; 73: 323-329.
37. Kleiman NS, White HD, Ohman EM, Ross AM, Woodlief LH, Catiff RM, et al. Mortality within 24 hours of thrombolysis for myocardial infarction: The importance of early reperfusion [The GUSTO Investigators: Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries]. Circulation 1994; 90: 2658-2665.